These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6594931)

  • 21. Induction of labour with prostaglandin E2 vaginal tablets.
    Khoo PP; Kalshekar M; Jogee M; Elder MG
    Eur J Obstet Gynecol Reprod Biol; 1981 Apr; 11(5):313-8. PubMed ID: 7194822
    [No Abstract]   [Full Text] [Related]  

  • 22. Absence of maternal side effects from prostaglandins used for cervical ripening.
    Goodlin RC; Reschl L; Clewell WH
    J Reprod Med; 1986 Dec; 31(12):1095-7. PubMed ID: 3467066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal prostaglandins and labour induction for patients previously delivered by caesarean section.
    MacKenzie IZ; Bradley S; Embrey MP
    Br J Obstet Gynaecol; 1984 Jan; 91(1):7-10. PubMed ID: 6581835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uterine rupture with the use of a low-dose vaginal PGE2 tablet.
    Azem F; Jaffa A; Lessing JB; Peyser MR
    Acta Obstet Gynecol Scand; 1993 May; 72(4):316-7. PubMed ID: 8389523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Labor induction with prostaglandin E2 in high-risk pregnancy].
    Andreev Zh; Borisov I
    Akush Ginekol (Sofiia); 1982; 21(1):70-8. PubMed ID: 7044168
    [No Abstract]   [Full Text] [Related]  

  • 26. Controlled trial of induction of labor by vaginal suppositories containing prostaglandin E2.
    Liggins GC
    Prostaglandins; 1979 Jul; 18(1):167-72. PubMed ID: 392623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rupture of the cervix during prostaglandin termination of pregnancy.
    El-Etriby EK; Daw E
    Postgrad Med J; 1981 Apr; 57(666):265-6. PubMed ID: 7291112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin vaginal suppositories: a simple and safe approach to the induction of labor.
    Shepherd JH; Bennett MJ; Laurence D; Moore F; Sims CD
    Obstet Gynecol; 1981 Nov; 58(5):596-600. PubMed ID: 6946350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of postpartum uterine atony with prostaglandin E2 vaginal suppositories.
    Hertz RH; Sokol RJ; Dierker LJ
    Obstet Gynecol; 1980 Jul; 56(1):129-30. PubMed ID: 6966776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uterine rupture with the use of PGE2 vaginal inserts for labor induction in women with previous cesarean sections.
    Taylor DR; Doughty AS; Kaufman H; Yang L; Iannucci TA
    J Reprod Med; 2002 Jul; 47(7):549-54. PubMed ID: 12170531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preparation of the uterine cervix before induction of labor using the prostaglandin E2 (PGE2) vaginal tablet].
    Lomícková T; Mandys F; Kovarík J
    Cesk Gynekol; 1987 Feb; 52(1):18-24. PubMed ID: 3552266
    [No Abstract]   [Full Text] [Related]  

  • 32. Prostaglandin E2 induction of labor for fetal demise.
    Kent DR; Goldstein AI
    Obstet Gynecol; 1976 Oct; 48(4):475-8. PubMed ID: 967387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simpler approach to labor induction using lipid-based prostaglandin E2 vaginal suppository.
    MacKenzie IZ; Bradley S; Embrey MP
    Am J Obstet Gynecol; 1981 Sep; 141(2):158-62. PubMed ID: 6945046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandins: an alternative concept for induction of labor.
    Shepherd JH; Knuppel RA
    South Med J; 1980 Nov; 73(11):1476-7. PubMed ID: 7444512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison between vaginal prostaglandin E2 suppositories and intrauterine extra-amniotic prostaglandins in the management of fetal death in utero.
    Scher J; Jeng DY; Moshirpur J; Kerenyi TD
    Am J Obstet Gynecol; 1980 Aug; 137(7):769-72. PubMed ID: 7405968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the safety and efficacy of intravaginal misoprostol (prostaglandin E1) with those of dinoprostone (prostaglandin E2) for cervical ripening and induction of labor in a community hospital.
    Blanchette HA; Nayak S; Erasmus S
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 1):1551-9. PubMed ID: 10368503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uterine hyperstimulation resulting from intravaginal prostaglandin E2. A case report.
    Chamberlin RO; Cohen GR; Knuppel RA
    J Reprod Med; 1987 Mar; 32(3):233-5. PubMed ID: 3471969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dramatic pyrexic and cardiovascular response to intravaginal prostaglandin E2.
    Phelan JP; Meguiar RV; Matey D; Newman C
    Am J Obstet Gynecol; 1978 Sep; 132(1):28-32. PubMed ID: 696780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of labor with a stable-based prostaglandin E2 vaginal tablet.
    Kennedy JH; Gordon-Wright AP; Stewart P; Calder AA; Elder MG
    Eur J Obstet Gynecol Reprod Biol; 1982 Jun; 13(4):203-8. PubMed ID: 6956526
    [No Abstract]   [Full Text] [Related]  

  • 40. Uterine rupture during induced trial of labor among women with previous cesarean delivery.
    Ravasia DJ; Wood SL; Pollard JK
    Am J Obstet Gynecol; 2000 Nov; 183(5):1176-9. PubMed ID: 11084562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.